Chad vs Philippines: Death rate from Alzheimer's
Chad
2.21 deaths per 100,000 people
in 2021
Philippines
2.2 deaths per 100,000 people
in 2021
Chad rank
186th
Philippines rank
187th
Death rate from Alzheimer's over time
- Chad
- Philippines
How they compare
Chad currently reports 2.21 deaths per 100,000 people against 2.2 deaths per 100,000 people in Philippines, a difference of 0.01 deaths per 100,000 people.
Across all 22 years both countries report, Chad has been ahead every year.
Chad ranks 186th and Philippines ranks 187th of 194 countries.
Chad has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chad | Philippines | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 2.95 deaths per 100,000 people | 0.495 deaths per 100,000 people | 2.45 deaths per 100,000 people | Chad |
| 2010s | 2.51 deaths per 100,000 people | 0.91 deaths per 100,000 people | 1.6 deaths per 100,000 people | Chad |
| 2020s | 2.33 deaths per 100,000 people | 1.88 deaths per 100,000 people | 0.45 deaths per 100,000 people | Chad |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher death rate from alzheimer's, Chad or Philippines?
- Chad, at 2.21 deaths per 100,000 people against 2.2 deaths per 100,000 people in Philippines as of 2021.
- What is the difference in death rate from alzheimer's between Chad and Philippines?
- 0.01 deaths per 100,000 people, with Chad ahead.
- How many years of comparable data are there for Chad and Philippines?
- 22 years are reported by both, from 2000 to 2021.
- How do Chad and Philippines rank globally for death rate from alzheimer's?
- Chad ranks 186th and Philippines ranks 187th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Death rate from Alzheimer's. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from alzheimer disease and other dementias in both sexes, per 100,000 people.